Skip to content

BHIVA: Kaletra monotherapy has benefits in clinical practice for highly treatment-experienced

Criminalisation of HIV transmission in the UK: how did we get here and where to now?

HIV-positive woman in Switzerland sentenced after having unprotected sex, even though partners knew she had HIV

Knowledge about HIV declining in UK against high levels of risk behaviour, opinion poll suggests

Growth hormone production reduced in HIV-positive men with fat redistribution

Variation in gene linked to risk of resistance after stopping efavirenz treatment

BHIVA: Half of all HIV-related discrimination comes from dentists, GPs and hospital staff

Ultra-sensitive test reveals highly variable patterns of NNRTI resistance decay

Risk of disease progression linked to CD4 cell count and HIV DNA level during primary infection

Next generation NRTI, DFC (Reverset) discontinued due to safety concerns

HIV incidence amongst injecting drug users in St Petersburg near 5%, highest in speed users

Cost of treatment and care becoming sensitive issue for UK as NHS faces spending slow-down

Malaria transmission factors and immunity play major roles in treatment response according to two Ugandan studies

Differing predictors of resistance to atazanavir/ritonavir or Kaletra identified

US government watchdog criticises PEPFAR prevention policy

How frequently are ARV side-effects being seen in resource-limited settings, and how are they dealt with?

HIV infection, viral load and injecting drug use linked to early signs of cardiovascular disease

High viral load and symptoms of primary infection mean worse survival, says study conducted in HIV-positive sex workers in Kenya